معرفی
Paul J. Catalano is a Senior Lecturer in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. He is affiliated with the Dana-Farber Cancer Institute, where he serves as a statistician for clinical trials and collaborates on cancer research.
His research focuses on biostatistical methods for analyzing multiple outcomes and repeated measures in environmental dose-response modeling, quantitative risk assessment, and neurotoxicity studies. He also develops software for implementing modeling algorithms and investigates experimental design in low-dose risk estimation.
Recent publications highlight collaborations in
- immunotherapy for urothelial carcinoma
- radiation therapy for brain metastases
- pediatric neuroblastoma treatment
- AI-driven MRI segmentation
Dr. Catalano's work extends to clinical trials in colorectal, genito-urinary, and breast cancer, with emphasis on prognostic factor identification and translational research.
